Positive effect of low-activity thromboxane A synthase 1 gene on prognosis in coronary heart disease
- Authors: Kopylov FY.1, Mesitskaya DF1, Nikitina Y.M1, Aksenova MG1, Dobrovolsky AV1, Lomakin OV1, Chernyi OV1
-
Affiliations:
- Issue: Vol 87, No 3 (2015)
- Pages: 59-65
- Section: Editorial
- Submitted: 10.04.2020
- Published: 15.03.2015
- URL: https://ter-arkhiv.ru/0040-3660/article/view/31714
- ID: 31714
Cite item
Full Text
Abstract
About the authors
F Yu Kopylov
D F Mesitskaya
Yu M Nikitina
M G Aksenova
A V Dobrovolsky
O V Lomakin
O V Chernyi
References
- Айнетдинова Д.Х. Резистентность к антитромбоцитарным препаратам у больных с острыми коронарными синдромами: Дис. ... канд. мед. наук. М 2008: 22—36.
- Sun Ah, Byung Lae, Jeong Ho. Association of polymorphisms in thromboxane A2 receptor and thromboxane A synthase 1 with cerebral infarction in a Korean population. BMB 2009; 42 (4): 200—205.
- Yu Fang, Yi Xue, Za Zhi. Association of Rs10487667 genetic polymorphism of thromboxane synthase with myocardial infarction in Uigur population of Xinjiang. Heart 2010; 44 (11): 1032—1036.
- Oh S.H., Kim Y.H., Park S.M. et al. Association analysis of thromboxane A synthase 1 gene polymorphisms with aspirin intolerance in asthmatic patients. Pharmacogenomics 2011; 12 (3): 351—363.
- Bhavaraju K., Georgakis A., Jin J. Antagonism of P2Y12 reduces physiological thromboxane levels. Platelets 2010; 21 (8): 604—609.